Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Paclitaxel Plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer: A Safety, Feasibility, and Efficacy Study from the Hoosier Oncology Group

2010; Elsevier BV; Volume: 5; Issue: 12 Linguagem: Inglês

10.1097/jto.0b013e3181f77b6e

ISSN

1556-1380

Autores

Shadia I. Jalal, Pablo M. Bedano, Lawrence H. Einhorn, Sumeet Bhatia, Rafat Ansari, Naftali Bechar, Karuna Koneru, Ramaswamy Govindan, Jingwei Wu, Menggang Yu, Bryan P. Schneider, Nasser H. Hanna,

Tópico(s)

Lung Cancer Treatments and Mutations

Referência(s)